NOTICE OF ALLOWANCE - ISSUED
issued
on 31 Dec 2024
Last Applicant/ Owned by
136-68 ROOSEVELT AVE, STE 821
FLUSHING
NY
11354
Serial Number
98393926 filed on 06th Feb 2024
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
FULLYGO
Health food supplements; Nutritional supplements; Nutritional supplements for boost immunity,support heart function and reduce fatigue; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels
Classification Information
Class [005]
Pharmaceutical Products
Health food supplements; Nutritional supplements; Nutritional supplements for boost immunity,support heart function and reduce fatigue; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98393926
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
02.11.13 -
Hearts used as background or carriers
05.03.25 -
Other leaves
27.03.04 -
Representations of plants or parts of plants forming letters or numerals, including punctuation
28.01.03 -
Japanese and Chinese characters Formerly Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Dec 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 19th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Nov 2024 | PUBLISHED FOR OPPOSITION |
| 13th Nov 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 07th Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 22nd Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 22nd Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 22nd Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 11th Sep 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 11th Sep 2024 | NON-FINAL ACTION E-MAILED |